Tacalcitol
Title | Journal |
---|---|
Interleukin-17- and protease-activated receptor 2-mediated production of CXCL1 and CXCL8 modulated by cyclosporine A, vitamin D3 and glucocorticoids in human keratinocytes. | The Journal of dermatology 20120701 |
Topical vitamin D₃ analogues induce thymic stromal lymphopoietin and cathelicidin in psoriatic skin lesions. | The British journal of dermatology 20120701 |
Effects of rotation of topical vitamin D3 in chronic plaque-type psoriasis. | The Journal of dermatology 20120301 |
The in-vitro antiproliferative effect of PRI-2191 and imatinib applied in combined treatment with cisplatin, idarubicin, or docetaxel on human leukemia cells. | Anti-cancer drugs 20120101 |
Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription. | The Journal of biological chemistry 20111021 |
The separate daily application of tacalcitol 4 µg/g ointment and budesonide 0.25 mg/g cream is more effective than the single daily application of a two compound ointment containing calcipotriol 50 µg/g and betamethasone dipropionate 0.5 mg/g. | Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 20110801 |
Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis. | The British journal of dermatology 20110401 |
Calcipotriol plus betamethasone dipropionate gel compared with tacalcitol ointment and the gel vehicle alone in patients with psoriasis vulgaris: a randomized, controlled clinical trial. | Dermatology (Basel, Switzerland) 20110101 |
Stereoselective synthesis of C24-hydroxylated vitamin D3 analogs: a practical and expeditius route to calcipotriol. | The Journal of steroid biochemistry and molecular biology 20100701 |
Vitamin D derivatives: calcitriol and tacalcitol inhibits interleukin-6 and interleukin-8 expression in human nasal polyp fibroblast cultures. | Advances in medical sciences 20100101 |
Biopsy proven morphea treated with tacalcitol ointment: case report. | Acta dermatovenerologica Croatica : ADC 20100101 |
Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients. | Acta bio-medica : Atenei Parmensis 20090401 |
Tacalcitol ointment for the treatment of nail psoriasis. | The Journal of dermatological treatment 20090101 |
Influence of vitamin D(3) analogues in combination with budesonid R on proliferation of nasal polyp fibroblasts. | Acta biochimica Polonica 20090101 |
Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model. | Cancer chemotherapy and pharmacology 20081001 |
The influence of 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 on alphavbeta3 integrin expression in cancer cell lines. | Oncology reports 20081001 |
Nail psoriasis: a combined treatment with 8% clobetasol nail lacquer and tacalcitol ointment. | Journal of the European Academy of Dermatology and Venereology : JEADV 20080801 |
Efficacy of high-concentration tacalcitol ointment in psoriasis vulgaris after changing from other high-concentration vitamin D3 ointments. | Dermatology online journal 20080227 |
Inhibitory effects of 1,25-dihydroxyvitamin D3 and its low-calcemic analogues on staurosporine-induced apoptosis. | Pharmacological reports : PR 20070101 |
The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics. | Oncology research 20070101 |
[The change of proliferative potential of fibroblasts derived of nasal polyps in vitro cultured, influenced by derivatives vitamins D]. | Otolaryngologia polska = The Polish otolaryngology 20070101 |
Daily versus intermittent application of high-concentration tacalcitol ointment in combination with low-dose cyclosporin for psoriasis vulgaris. | The Journal of dermatology 20060201 |
Antiproliferative activity of vitamin D compounds in combination with cytostatics. | Anticancer research 20060101 |
Involvement of PI3-K in neuroprotective effects of the 1,25-dihydroxyvitamin D3 analogue - PRI-2191. | Pharmacological reports : PR 20060101 |
Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice. | Endocrinology 20051201 |
Profile of clinical efficacy and safety of topical tacalcitol. | Acta bio-medica : Atenei Parmensis 20050401 |
Effects of PRI-2191--a low-calcemic analog of 1,25-dihydroxyvitamin D3 on the seizure-induced changes in brain gene expression and immune system activity in the rat. | Brain research 20050328 |
Does the determination of the Bb vitamin D receptor genotype identify psoriasis vulgaris patients responsive to topical tacalcitol? | Journal of dermatological science 20050301 |
Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris. | Dermatology (Basel, Switzerland) 20050101 |
Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics. | Anticancer research 20050101 |
Tolerance to calcitriol and tacalcitol in three patients with allergic contact dermatitis to calcipotriol. | Journal of drugs in dermatology : JDD 20050101 |
Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: 'right-left intra-individual pre/post comparison design'. | International journal of immunopathology and pharmacology 20050101 |
Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191). | Steroids 20040901 |
Neuroprotective effects of (24R)-1,24-dihydroxycholecalciferol in human neuroblastoma SH-SY5Y cell line. | The Journal of steroid biochemistry and molecular biology 20040501 |
Anti-inflammatory effects of tacalcitol (1,24(R)(OH)2D3, TV-02) in the skin of TPA-treated hairless mice. | The Journal of dermatology 20040301 |
[Treatment of scalp psoriasis. An effective and safe tacalcitol emulsion]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20040201 |
Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial. | Dermatology (Basel, Switzerland) 20040101 |
Iatrogenic hypercalcemia due to vitamin D3 ointment (1,24(OH)2D3) combined with thiazide diuretics in a case of psoriasis. | The Journal of dermatology 20031101 |
Pharmacological profiles of high-concentration (20 microg/g) tacalcitol ointment: effects on cutaneous inflammation, epidermal proliferation, and differentiation in mice. | The Journal of dermatology 20030701 |
Similarly potent action of 1,25-dihydroxyvitamin D3 and its analogues, tacalcitol, calcipotriol, and maxacalcitol on normal human keratinocyte proliferation and differentiation. | Journal of dermatological science 20030201 |
A systematic review of adverse effects associated with topical treatments for psoriasis. | Dermatology online journal 20030201 |
Histometric assessment of psoriatic plaques treated by vitamin D3 derivatives. | Dermatology (Basel, Switzerland) 20030101 |
Steroid hormone action in musculoskeletal cells involves membrane receptor and nuclear receptor mechanisms. | Connective tissue research 20030101 |
The third multidisciplinary conference on drug research, Piła 2002. Effects of 1alpha,25-dihydroxyvitamin D3 and some putative steroid neuroprotective agents on the hydrogen peroxide-induced damage in neuroblastoma-glioma hybrid NG108-15 cells. | Acta poloniae pharmaceutica 20030101 |
Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris. | Journal of dermatological science 20021101 |
Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. | Cancer research 20021101 |
A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis. | The British journal of dermatology 20021001 |
Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis. | The British journal of dermatology 20020301 |
Confluent and reticulated papillomatosis (Gougerot-Carteaud) successfully treated with tacalcitol. | The Journal of dermatological treatment 20020301 |
[1 alpha, 25-dihydroxyvitamin D3 and its analogues modulate the phagocytosis of human monocyte-derived dendritic cells]. | Yao xue xue bao = Acta pharmaceutica Sinica 20020201 |
Vascular variant of keratosis lichenoides chronica associated with hypothyroidism and response to tacalcitol and acitretin. | Acta dermato-venereologica 20020101 |
Explosive diaper pustular psoriasis. | Pediatric dermatology 20020101 |
24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation. | Cancer research 20010415 |
Dimer and superstructure of the active form of a vitamin D3; 1 alpha,24(R)dihydroxy-vitamin D3 monohydrate, C27O3H44.H2O. | Chemical & pharmaceutical bulletin 20010301 |
The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity. | European journal of dermatology : EJD 20010101 |
Hyperkeratosis lenticularis perstans (Flegel's disease)--lack of response to treatment with tacalcitol and calcipotriol. | Dermatology (Basel, Switzerland) 20010101 |
New developments in the treatment of psoriasis. | Skin pharmacology and applied skin physiology 20010101 |
Enhancement of the antiparakeratotic potency of calcitriol and tacalcitol in liposomal preparations in the mouse tail test. | Skin pharmacology and applied skin physiology 20010101 |
Effects of calcitriol and its analogues on interaction of MCP-1 and monocyte derived dendritic cells in vitro. | Acta pharmacologica Sinica 20010101 |
Comparison of the relative effects of 1,24-dihydroxyvitamin D(2) [1, 24-(OH)(2)D(2)], 1,24-dihydroxyvitamin D(3) [1,24-(OH)(2)D(3)], and 1,25-dihydroxyvitamin D(3) [1,25-(OH)(2)D(3)] on selected vitamin D-regulated events in the rat. | Biochemical pharmacology 20000901 |
Profile of ligand specificity of the vitamin D binding protein for 1 alpha,25-dihydroxyvitamin D3 and its analogs. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 19940801 |
1 alpha,24R-dihydroxyvitamin D3 has an ability comparable to that of 1 alpha,25-dihydroxyvitamin D3 to induce keratinocyte differentiation. | The Journal of dermatology 19901101 |